These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4859584)

  • 1. Vascular responses in the hands of Parkinson's disease patients.
    Elliott K; Côté LJ; Frewin DB
    Neurology; 1974 Sep; 24(9):857-62. PubMed ID: 4859584
    [No Abstract]   [Full Text] [Related]  

  • 2. Autonomic deficits in Parkinson's syndrome.
    Appenzeller O; Goss JE
    Arch Neurol; 1971 Jan; 24(1):50-7. PubMed ID: 5539987
    [No Abstract]   [Full Text] [Related]  

  • 3. Autonomic dysfunction in Parkinson's syndrome.
    Appenzeller O; Goss J
    Trans Am Neurol Assoc; 1970; 95():200-3. PubMed ID: 5514369
    [No Abstract]   [Full Text] [Related]  

  • 4. Reflex vasomotor responses in the hands of patients suffering from migraine.
    Elliott K; Frewin DB; Downey JA
    Headache; 1974 Jan; 13(4):188-96. PubMed ID: 4810474
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal thermography in Parkinson's disease.
    Antonio-Rubio I; Madrid-Navarro CJ; Salazar-López E; Pérez-Navarro MJ; Sáez-Zea C; Gómez-Milán E; Mínguez-Castellanos A; Escamilla-Sevilla F
    Parkinsonism Relat Disord; 2015 Aug; 21(8):852-7. PubMed ID: 26003411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of psychometic tests in 23 patients with Parkinson's disease after 6 months treatment with L-dopa].
    Barbizet J; Duizabo P; Pasquier M
    Rev Neurol (Paris); 1972 Aug; 127(2):311-3. PubMed ID: 4666638
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-range motor performance changes in levodopa-treated patients with Parkinson's disease.
    Birdsong JH; McKinney AS
    Neurology; 1974 Feb; 24(2):107-15. PubMed ID: 4855677
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
    Mazza C; Buffatti PF; Bazzan A; Lion P
    Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378
    [No Abstract]   [Full Text] [Related]  

  • 9. Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.
    Malarkey WB; Cyrus J; Paulson GW
    J Clin Endocrinol Metab; 1974 Aug; 39(2):229-35. PubMed ID: 4371345
    [No Abstract]   [Full Text] [Related]  

  • 10. Polysynaptic spinal reflexes in Parkinson's disease.
    Delwaide PJ; Schwab RS; Young RR
    Neurology; 1974 Sep; 24(9):820-7. PubMed ID: 4859445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modern therapeutics of Parkinson's disease].
    Schott B
    Lyon Med; 1971 Nov; 226(17):539-46. PubMed ID: 5134684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Parkinson's disease with levodopa].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
    Lipman IJ; Papadopoulos NM
    Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease.
    Van Woert MH
    Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in pulmonary function in Parkinson's syndrome after treatment with L-DOPA.
    Langer H; Woolf CR
    Am Rev Respir Dis; 1971 Sep; 104(3):440-2. PubMed ID: 5098678
    [No Abstract]   [Full Text] [Related]  

  • 18. Current concepts in the management of Parkinson's disease.
    Chapman WG
    West Indian Med J; 1974 Mar; 23(1):61-4. PubMed ID: 4456821
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of cortisol secretion in Parkinson's syndrome and narcolepsy.
    Gallagher BB
    J Clin Endocrinol Metab; 1971 Jun; 32(6):796-800. PubMed ID: 4325218
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa for Parkinson's disease; some limitations in its use.
    Gillen HW
    Med Trial Tech Q; 1973; 19(4):400-8. PubMed ID: 4710961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.